Story perspectives
Doctors Urge Research on Mifepristone's Breast Cancer Benefits
8/16/2025
48 3
1 of 1
Story summary
- Doctors from various countries call for increased research on mifepristone's potential to reduce breast cancer risk.
- Existing studies indicate it may limit progesterone effects, yet pharmaceutical companies are reluctant due to abortion controversies.
- Lead author Kristina Gemzell Danielsson highlights regulatory challenges and stigma as barriers to further research.
- Breast cancer is a major cause of cancer-related deaths among women worldwide.
